
8.45 Delayed Data As of Dec 01 | ![]() Today’s Change | 8.31 Today|||52-Week Range 17.00 | -34.29% Year-to-Date |
Bristol Myers (BMY), TSVT Cell Therapy Abecma Faces Setback Nov 21 / Zacks.com - Paid Partner Content | Bayer (BAYRY) Stops Heart Drug Study Due to Lack of Efficacy Nov 20 / Zacks.com - Paid Partner Content |
Previous close | 8.52 |
Today’s open | 8.36 |
Day’s range | 8.33 - 8.45 |
Volume | 1,336,991 |
Average volume (3 months) | 1,200,786 |
Market cap | $33.2B |
Earnings growth (last year) | +268.98% |
Earnings growth (this year) | -10.42% |
Earnings growth (next 5 years) | +0.40% |
Revenue growth (last year) | +2.35% |
P/E ratio | -- |
Price/Sales | 0.95 |
Price/Book | 0.80 |
No competitors data available. |
Next reporting date | March 5, 2024 |
EPS forecast (this quarter) | $0.39 |
Annual revenue (last year) | $53.3B |
Annual profit (last year) | $4.4B |
Net profit margin | 8.18% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Leverkusen, Nordrhein-westfalen |